By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Federal Health Workforce Faces Unprecedented Job Security Changes Under New Classification

Federal Health Workforce Faces Unprecedented Job Security Changes Under New Classification

GMJ
Last updated: 16/07/2026 00:35
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Federal health agency workers discussing policy changes in government office setting
Thousands of federal health workers at HHS agencies including CDC, FDA, and NIH have been reclassified under Schedule F status, removing job protections. The change allows easier termination of policy staff for political reasons rather than performance issues. — "Army scientists energize battery research" by U.S. Army Combat Capabilities Development Command is licensed under CC BY-SA 2.0. To view a copy of this license, visit https://creativecommons.org/licenses/by-sa/2.0/. (CC BY-SA 2.0)
SHARE
1 min read|128 words

The Trump Administration has reclassified thousands of federal health workers under Schedule F employment status, fundamentally altering protections for staff across the Department of Health and Human Services. The policy change affects epidemiologists, regulatory experts, and research leaders at the CDC, FDA, NIH, and other critical agencies.

Under this new classification, career civil servants lose traditional merit-based job protections that have defined federal employment for decades. Workers in policy-shaping roles now serve at the discretion of political appointees, creating conditions where termination can occur based on policy disagreements rather than performance metrics.

This shift marks a significant transformation in how the federal government approaches health workforce management and raises questions about continuity in public health operations, disease surveillance, and regulatory oversight.

Read the full article on GMJ Newsroom.

Submit Your Paper
GMJ_Submit_Banner

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Trump Administration Removes Job Protections for Thousands of Federal Health Workers →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK’s MHRA Launches Innovation Guidance to Accelerate Medical Device and Drug Development

The UK's MHRA has published formal guidance for drug and medical device…

Rural Healthcare’s $50 Billion Question: Can Technology Alone Solve Workforce Shortages?

A $50 billion US rural healthcare investment prioritises technology infrastructure, but health…

FDA-Approved Drug Restores Immunotherapy Efficacy in Rare Liver Cancer by Releasing Trapped T Cells

Researchers have identified that rare liver cancers evade immunotherapy by trapping immune…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Stadium crowd at international sporting event showing dense gathering conditions

Three Essential Facts About Infectious Disease Risk at International Sporting Events

By
Prof. Giorgi Pkhakadze
17/07/2026
Cancer risk comparison across tobacco product categories in Indian multicentre study

New Multicentre Study Confirms Bidi Smoking as Significant Cancer Risk Factor in India

By
Prof. Giorgi Pkhakadze
16/07/2026
Comparative chart showing cafestol content in boiled, French press, espresso, and filtered coffee brewing methods

Filter Your Coffee, Not Your Cholesterol Concerns: How Brewing Method Changes Everything

By
Prof. Giorgi Pkhakadze
23/07/2026
Medical professional discussing GLP-1 medication safety and dosing concerns

Three Critical Safety Issues With GLP-1 Microdosing You Need to Know

By
Prof. Giorgi Pkhakadze
29/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up